Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit

Clin Infect Dis. 2013 Mar;56(5):697-700. doi: 10.1093/cid/cis969. Epub 2012 Nov 15.

Abstract

A carbapenem-sparing regimen of tigecycline plus gentamicin or colistin was effective for treating 24 of 26 (92%) Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infectious episodes in 22 polytrauma intensive care unit patients without comorbidities. The 30-day crude mortality rate was 14%. Regimens were considered appropriate in 12% of episodes according to the Vitek 2 System and in 100% based on E-test.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Proteins / metabolism*
  • Carbapenems / therapeutic use
  • Colistin / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Gentamicins / therapeutic use*
  • Humans
  • Intensive Care Units
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / enzymology*
  • Male
  • Middle Aged
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Retrospective Studies
  • Tigecycline
  • Treatment Outcome
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • Gentamicins
  • Tigecycline
  • beta-Lactamases
  • carbapenemase
  • Minocycline
  • Colistin